Business Week news from FierceFinance

Quantitative analysis (quantitative news) is the subject of a new book that's benefiting at least from sheer topicality. It's no secret that Wall Street was smitten with this new, modern approach to... Read more...

We noted recently that hedge funds are having an easier time at fund raising than private equity funds. In fact, hedge funds took in $54 billion in new investments in August, September, October and... Read more...

Goldman Sachs' plan to pay its top 30 executives in shares-at-risk, which cannot be cashed out for five years, generated a lot of media attention. Most noted that the plan was a response to the PR... Read more...

There was a day when venture capital investing really mattered. In the 1990s and much of the 2000s, venture capital was acknowledged as a bright spot in the tech industry and economy; VC investments... Read more...

There was a day when the battle to colonize the desktop on Wall Street and beyond riveted many, when the players went beyond big names like Dow Jones and Reuters to upstarts like EJV (remember them?)... Read more...

As Wall Street continues to cheer, the jury acquittals of Ralph Cioffi and Matthew Tannin continue to reverberate. Business Week notes there are plenty of unanswered questions. Chief among them is... Read more...

Something has been overlooked a bit in Judge Jed Rakoff's rejection of the SEC's $33 million settlement with Bank of America: The whole concept of shareholder suits. One reason the judge rejected... Read more...

While the big banks seem to be on the mend, slowly anyway, Fannie and Freddie are sinking further into the morass of the credit crisis. You have to wonder how they might be salvaged. Business Week... Read more...

Investment bankers are hardly sitting around watching YouTube and playing computer golf. They're working on some big deals, like the IBM purchase of SPSS. We might see more fruits from that labor in... Read more...

Investment bankers tend to be an optimistic lot, convinced that the next big deal is right around the corner. There's hope but not a whole lot more right now. Sure, we've seen some big pharmaceutical... Read more...